News

Easebuzz reports profit in the seventh consecutive year; aims to cross $100Mn run rate over the next 12-18 months Easebuzz, India’s fast growing digital payments platform, has released its FY23 financial numbers. The annual Gross Transaction Value (GTV) processed by the platform during the year crossed at a record INR 70,000 Crores, a 2.5x growth rate over FY22. The daily volume run rate of the platform touched 400K transactions. Easebuzz has seen a significant momentum in revenue of INR 236 Crores ($29Mn), a growth of more than 90%. The company has remained profitable since inception. The ...
Easebuzz reports profit in the seventh consecutive year; aims to cross $100Mn run rate over the next 12-18 months
Easebuzz reports profit in the seventh consecutive year; aims to cross $100Mn run rate over the next 12-18 months
Source: PR Agency
17/07/2023 5:39:12 PM
Indoco Remedies moves up on getting EU GMP certification for Goa manufacturing site Indoco Remedies is currently trading at Rs. 324.35, up by 1.60 points or 0.50% from its previous closing of Rs. 322.75 on the BSE. The scrip opened at Rs. 323.80 and has touched a high and low of Rs. 327.00 and Rs. 323.15 respectively. So far 3621 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 423.10 on 02-Jan-2023 and a 52 week low of Rs. 307.00 on 26-Apr-2023. Last one week high and low of the scrip stood at ...
Indoco Remedies moves up on getting EU GMP certification for Goa manufacturing site
Indoco Remedies moves up on getting EU GMP certification for Goa manufacturing site
Source: Accord Fintech
12/07/2023 11:54:28 AM
Indoco Remedies gains on acquiring 85% stake in FPP Holding Company Indoco Remedies is currently trading at Rs. 335.75, up by 2.20 points or 0.66% from its previous closing of Rs. 333.55 on the BSE. The scrip opened at Rs. 337.00 and has touched a high and low of Rs. 337.00 and Rs. 331.90 respectively. So far 4060 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 423.10 on 02-Jan-2023 and a 52 week low of Rs. 307.00 on 26-Apr-2023. Last one week high and low of the scrip stood at ...
Indoco Remedies gains on acquiring 85% stake in FPP Holding Company
Indoco Remedies gains on acquiring 85% stake in FPP Holding Company
Source: Accord Fintech
6/06/2023 10:01:54 AM
Lupin gains on launching Darunavir Tablets Lupin is currently trading at Rs. 822.10, up by 4.95 points or 0.61% from its previous closing of Rs. 817.15 on the BSE. The scrip opened at Rs. 823.15 and has touched a high and low of Rs. 830.30 and Rs. 818.35 respectively. So far 22411 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 830.30 on 05-Jun-2023 and a 52 week low of Rs. 592.55 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs. 830.3...
Lupin gains on launching Darunavir Tablets
Lupin gains on launching Darunavir Tablets
Source: Accord Fintech
5/06/2023 10:04:06 AM
Barracuda makes websites, applications, and APIs security seamless with comprehensive enterprise-grade protection New Application Protection plans with ML-powered vulnerability, API, DDoS, and bot protection plus Zero Trust security help prevent today’s most complex threats  Barracuda Networks, Inc., a trusted partner and leading provider of cloud-first security solutions, today introduced new Application Protection plans to make it easy for customers to protect websites, applications, and APIs with comprehensive enterprise-grade protection. The new plans combine Machine Learning ...
Barracuda makes websites, applications, and APIs security seamless with comprehensive enterprise-grade protection
Barracuda makes websites, applications, and APIs security seamless with comprehensive enterprise-grade protection
Source: PR Agency
25/04/2023 10:05:39 AM
Lentra forays into Southeast Asia, aims $100 mn in ARR by 2024  Digital lending Cloud platform Lentra on Tuesday announced its entry into the South East Asian markets of Indonesia, the Philippines and Vietnam to cater to their growing lending needs. With this expansion, Lentra aims to reach $100 million in annual recurring revenue (ARR) by March 2024. The move follows the company's latest fundraise of $60 million in a Series B round led by Bessemer Venture Partners, Susquehanna International Group (SIG), and Citi Ventures. Lentra said i...
Lentra forays into Southeast Asia, aims $100 mn in ARR by 2024
Lentra forays into Southeast Asia, aims $100 mn in ARR by 2024
Source: IANS
14/02/2023 11:47:53 AM
India's Laurus Labs posts 32% profit jump on demand for drug ingredients  India's Laurus Labs Ltd reported a 32.1% rise in third-quarter profit on Monday, boosted by strong demand in its businesses that make chemicals and other ingredients used in medicines. The company's consolidated profit rose to 2.03 billion rupees (nearly $25 million) in the three months ended Dec. 31, from 1.54 billion rupees a year earlier. Revenue at Laurus Labs, which also makes hepatitis C and oncology drugs, rose more than 50% to 15.45 billion rupees. Laurus Labs s...
India's Laurus Labs posts 32% profit jump on demand for drug ingredients
India's Laurus Labs posts 32% profit jump on demand for drug ingredients
Source: Reuters
30/01/2023 12:47:41 PM
Travel fintech platform SanKash to hire over 500 in India in next 6 months Travel fintech platform SanKash on Monday said it plans to hire 500 professionals in India over the next six months. The platforms said that the new hires will fuel SanKash's sales and operations feet on street capability to cater to its existing travel merchant base of 6,000 spread across 250 cities, and increase its ground presence at 150,000 travel point of sale which dominate the domestic travel market. "With the market picking up post-Covid, travel merchants are seeing sig...
Travel fintech platform SanKash to hire over 500 in India in next 6 months
Travel fintech platform SanKash to hire over 500 in India in next 6 months
Source: IANS
6/12/2022 9:54:54 AM
Ami Organics rises as Small Cap World Fund buys 15.97 lakh shares AMI Organics is currently trading at Rs. 1119.00, up by 8.55 points or 0.77% from its previous closing of Rs. 1110.45 on the BSE. The scrip opened at Rs. 1125.00 and has touched a high and low of Rs. 1152.95 and Rs. 1110.00 respectively. So far 38420 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1438.50 on 22-Sep-2021 and a 52 week low of Rs. 764.15 on 24-Feb-2022. Last one week high and low of the scrip stoo...
Ami Organics rises as Small Cap World Fund buys 15.97 lakh shares
Ami Organics rises as Small Cap World Fund buys 15.97 lakh shares
Source: Accord Fintech
14/09/2022 1:11:42 PM
Fermenta Biotech surges on signing agreement with Aurigene Pharmaceutical Services Fermenta Biotech is currently trading at Rs. 297.40, up by 7.50 points or 2.59% from its previous closing of Rs. 289.90 on the BSE. The scrip opened at Rs. 293.00 and has touched a high and low of Rs. 304.00 and Rs. 293.00 respectively. So far 4550 shares were traded on the counter. The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 370.00 on 29-Jun-2021 and a 52 week low of Rs. 249.00 on 31-Mar-2021. Last one week high and low of the scrip stood at...
Fermenta Biotech surges on signing agreement with Aurigene Pharmaceutical Services
Fermenta Biotech surges on signing agreement with Aurigene Pharmaceutical Services
Source: Accord Fintech
21/01/2022 10:13:01 AM
First acquisition of listed firm by Indian unicorn: Pharmeasy picks up 66.1% in Thyrocare API Holdings Ltd (API), the parent company of digital healthcare brand Pharmeasy, is set to acquire automated accredited diagnostic laboratory Thyrocare Technologies, making the first such deal of a listed entity by an Indian unicorn. API Holdings has signed definitive documents to acquire 66.1 per cent stake in Thyrocare Technologies Ltd (Thyrocare) from Dr A. Velumani and affiliates at a price of Rs 1,300 per share aggregating to Rs 4,546 crore. The transaction is subject to regulator...
First acquisition of listed firm by Indian unicorn: Pharmeasy picks up 66.1% in Thyrocare
First acquisition of listed firm by Indian unicorn: Pharmeasy picks up 66.1% in Thyrocare
Source: IANS
26/06/2021 10:09:59 AM